(Q33534201)

27 July 2017

1 reference

title

Is there a standard adjuvant treatment for rectal cancer? (English)

1 reference

27 July 2017

Tveit KM

1

1 reference

27 July 2017

Nordlinger B

series ordinal

2

1 reference

27 July 2017

Penna C

series ordinal

3

1 reference

27 July 2017

Schmoll HJ

series ordinal

4

1 reference

27 July 2017

publication date

1 November 1998

1 reference

European Journal of Cancer

27 July 2017

published in

1 reference

27 July 2017

volume

34

1 reference

27 July 2017

issue

12

1 reference

27 July 2017

page(s)

1827-1835

1 reference

Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Prolongation of the disease-free interval in surgically treated rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Survival after postoperative combination treatment of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Pre-operative radiotherapy for rectal cancer: what benefit? Which technical parameters?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Improved survival with preoperative radiotherapy in resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900257-3

7 January 2021

10.1016/S0959-8049(98)00257-3

Identifiers

DOI

1 reference

27 July 2017

1 reference